Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 문지용 | - |
dc.date.accessioned | 2022-10-13T01:43:59Z | - |
dc.date.available | 2022-10-13T01:43:59Z | - |
dc.date.issued | 2021-01 | - |
dc.identifier.citation | CANCER RESEARCH AND TREATMENT, v. 53, no. 3, page. 678-684 | en_US |
dc.identifier.issn | 1598-2998; 2005-9256 | en_US |
dc.identifier.uri | https://www.e-crt.org/journal/view.php?doi=10.4143/crt.2020.1242 | en_US |
dc.identifier.uri | https://repository.hanyang.ac.kr/handle/20.500.11754/175320 | - |
dc.description.abstract | Purpose: This study aimed to analyze whether patients with lung cancer have a higher susceptibility of coronavirus disease 2019 (COVID-19), severe presentation, and higher mortality than those without lung cancer. Materials and Methods: A nationwide cohort of confirmed COVID-19 (n=8,070) between January 1, 2020, and May 30, 2020, and a 1:15 age-, sex-, and residence-matched cohort (n=121,050) were constructed. A nested case-control study was performed to compare the proportion of patients with lung cancer between the COVID-19 cohort and the matched cohort. Results: The proportion of patients with lung cancer was significantly higher in the COVID-19 cohort (0.5% [37/8,070]) than in the matched cohort (0.3% [325/121,050]) (p=0.002). The adjusted odds ratio [OR] of having lung cancer was significantly higher in the COVID-19 cohort than in the matched cohort (adjusted OR, 1.51; 95% confidence interval [CI], 1.05 to 2.10). Among patients in the COVID-19 cohort, compared to patients without lung cancer, those with lung cancer were more likely to have severe COVID-19 (54.1% vs. 13.2%, p < 0.001), including mortality (18.9% vs. 2.8%, p < 0.001). The adjusted OR for the occurrence of severe COVID-19 in patients with lung cancer relative to those without lung cancer was 2.24 (95% CI, 1.08 to 4.74). Conclusion: The risk of COVID-19 occurrence and severe presentation, including mortality, may be higher in patients with lung cancer than in those without lung cancer. | en_US |
dc.description.sponsorship | This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HC19C0318). | en_US |
dc.language.iso | en | en_US |
dc.publisher | KOREAN CANCER ASSOCIATION | en_US |
dc.subject | COVID-19; Lung neoplasms; Mortality | en_US |
dc.title | Risk of Coronavirus Disease 2019 Occurrence, Severe Presentation, and Mortality in Patients with Lung Cancer | en_US |
dc.type | Article | en_US |
dc.relation.no | 3 | - |
dc.relation.volume | 53 | - |
dc.identifier.doi | 10.4143/crt.2020.1242 | en_US |
dc.relation.page | 678-684 | - |
dc.relation.journal | CANCER RESEARCH AND TREATMENT | - |
dc.contributor.googleauthor | Yang, Bumhee | - |
dc.contributor.googleauthor | Choi, Hayoung | - |
dc.contributor.googleauthor | Lee, Sun-Kyung | - |
dc.contributor.googleauthor | Chung, Sung Jun | - |
dc.contributor.googleauthor | Yeo, Yoomi | - |
dc.contributor.googleauthor | Shin, Yoon Mi | - |
dc.contributor.googleauthor | Park, Dong Won | - |
dc.contributor.googleauthor | Park, Tai Sun | - |
dc.contributor.googleauthor | Moon, Ji-Yong | - |
dc.contributor.googleauthor | Kim, Tae-Hyung | - |
dc.relation.code | 2021009495 | - |
dc.sector.campus | S | - |
dc.sector.daehak | COLLEGE OF MEDICINE[S] | - |
dc.sector.department | DEPARTMENT OF MEDICINE | - |
dc.identifier.pid | moonji | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.